Cultures of PF ADSCs and BC ADSCs at different passages (lower than passage 4) were phenotypically characterized following reference guidelines [32 (
link), 33 (
link)]. ADSCs obtained from PF- or BC-bearing patients were detached with 0.05%
trypsin/EDTA (Thermo Fisher), washed with PBS, and 100000 cells were resuspended in 250
μL of PBS without Ca
2+ and Mg
+ (Euroclone, Pero, Italy) and incubated with antibodies directed against specific surface markers. Cells were incubated on ice for 30 minutes with antibodies
anti-CD44 (BD Biosciences, San Jose, CA),
anti-CD90 (Millipore, Massachusetts, USA),
anti-CD34 (Miltenyi Biotec, Calderara di Reno, BO, Italy),
anti-CD45 (BD Biosciences),
anti-CD146 (Biocytex, USA),
anti-CD31 (Miltenyi Biotec),
anti-CD56 (Miltenyi Biotec), anti-CD105 (Serotec, Bio-Rad, Segrate, MI, Italy),
anti-CD144 (R&D Systems, Minneapolis, MN, USA),
anti-CD166 (BD Biosciences),
anti-CD133/2 (Miltenyi Biotec),
anti-CD73 (BD Biosciences), and anti-vascular endothelial growth factor 2 (VEGFR2; R&D Systems). Cells were pelleted, washed, and fixed in 4%
paraformaldehyde (Sigma-Aldrich) for 20 minutes. Fluorescence-activated cell sorting (FACS) analysis was performed on a
FACSVerse flow cytometer (BD Biosciences), equipped with the Cell Sweet software for data analysis.
Rey F., Lesma E., Massihnia D., Ciusani E., Nava S., Vasco C., Al Haj G., Ghilardi G., Opocher E., Gorio A., Carelli S, & Di Giulio A.M. (2019). Adipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities. Stem Cells International, 2019, 1480314.